RATES AND RISK Daniel E. Ford, MD, MPH Johns Hopkins School of Medicine Introduction to Clinical Research July 12, 2010.

Slides:



Advertisements
Similar presentations
Measures of Disease Frequency
Advertisements

M2 Medical Epidemiology
1 Case-Control Study Design Two groups are selected, one of people with the disease (cases), and the other of people with the same general characteristics.
STUDY DESIGN CASE SERIES AND CROSS-SECTIONAL
Measures of Impact Dublin June Measures of Impact You want to reduce deaths from road traffic accidents Most impact for least cost Cohort study.
Unit 14: Measures of Public Health Impact.
What type of study is this?
Extension Article by Dr Tim Kenny
Understanding real research 3. Assessment of risk.
MEASURES IN EPIDEMIOLOGY
Measures of association
Measures of disease frequency (I). MEASURES OF DISEASE FREQUENCY Absolute measures of disease frequency: –Incidence –Prevalence –Odds Measures of association:
HaDPop Measuring Disease and Exposure in Populations (MD) &
Measuring Epidemiologic Outcomes
COHORT STUDY DR. A.A.TRIVEDI (M.D., D.I.H.) ASSISTANT PROFESSOR
Understanding study designs through examples Manish Chaudhary MPH (BPKIHS)
Mapping Rates and Proportions. Incidence rates Mortality rates Birth rates Prevalence Proportions Percentages.
How do cancer rates in your area compare to those in other areas?
BC Jung A Brief Introduction to Epidemiology - IV ( Overview of Vital Statistics & Demographic Methods) Betty C. Jung, RN, MPH, CHES.
Lecture 3: Measuring the Occurrence of Disease
Multiple Choice Questions for discussion
Week 2. What is epidemiology?  Key science of public health  Focuses on examining the distribution of disease across the population  Use of largely.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar Dr.PH. Batch 5 1.
Retrospective Cohort Study. Review- Retrospective Cohort Study Retrospective cohort study: Investigator has access to exposure data on a group of people.
Chapter 3: Measures of Morbidity and Mortality Used in Epidemiology
Measures of Association
Prospective Studies (cohort, longitudinal, incidence studies) Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public.
Approaches to the measurement of excess risk 1. Ratio of RISKS 2. Difference in RISKS: –(risk in Exposed)-(risk in Non-Exposed) Risk in Exposed Risk in.
Patricia Cohen, Ph.D. Henian Chen, M.D., Ph. D. Teaching Assistants Julie KranickSylvia Taylor Chelsea MorroniJudith Weissman Applied Epidemiologic Analysis.
Statistics for clinicians Biostatistics course by Kevin E. Kip, Ph.D., FAHA Professor and Executive Director, Research Center University of South Florida,
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar DrPH Batch 5 1.
Epidemiology: Basic concepts and principles ENV
Measuring associations between exposures and outcomes
Basic concept of clinical study
Epidemiologic Measures Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /4/20151.
EVIDENCE BASED PRACTICE BY MOHEB KHOUZAM MD. EVIDENCE BASED PRACTICE  1- TYPES OF STUDY DESIGNS  2- RECOMMENDATIONS.
Standardization of Rates. Rates of Disease Are the basic measure of disease occurrence because they most clearly express probability or risk of disease.
Measuring Associations Between Exposure and Outcomes Chapter 3, Szklo and Nieto.
Instructor Resource Chapter 3 Copyright © Scott B. Patten, Permission granted for classroom use with Epidemiology for Canadian Students: Principles,
1 Multivariable Modeling. 2 nAdjustment by statistical model for the relationships of predictors to the outcome. nRepresents the frequency or magnitude.
Measures of Disease Frequency
Organization of statistical research. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and.
CHP400: Community Health Program - lI Research Methodology STUDY DESIGNS Observational / Analytical Studies Cohort Study Present: Disease Past: Exposure.
Matching. Objectives Discuss methods of matching Discuss advantages and disadvantages of matching Discuss applications of matching Confounding residual.
Case Control Studies Dr Amna Rehana Siddiqui Department of Family and Community Medicine October 17, 2010.
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
Chapter 3 Descriptive Statistics for Qualitative Data.
Basic Concepts of Epidemiology & Social Determinants of Health Prof. Supannee Promthet 27 Septmber 2013:
III. Measures of Morbidity: Morbid means disease. Morbidity is an important part of community health. It gives an idea about disease status in that community.
MODULE TWO: Epidemiologic Measurements: An Overview.
Methods of quantifying disease Stuart Harris Public Health Intelligence Analyst Course – Day 3.
Chapter 2. **The frequency distribution is a table which displays how many people fall into each category of a variable such as age, income level, or.
Measures of disease frequency Simon Thornley. Measures of Effect and Disease Frequency Aims – To define and describe the uses of common epidemiological.
Epidemiological measureas. How do we determine disease frequency for a population?
Chapter 9: Case Control Studies Objectives: -List advantages and disadvantages of case-control studies -Identify how selection and information bias can.
Instructional Objectives:
Comparison of three Observational Analytical strategies
بسم الله الرحمن الرحيم COHORT STUDIES.
Study Designs Hale Arık Taşyıkan, MD, MPH, Assist. Prof.
College of Applied Medical Sciences
INDIRECT STANDARDIZATION BY MBBSPPT.COM
Epidemiology MPH 531 Analytic Epidemiology Cohort Studies
Measurements of Risk & Association …
Mpundu MKC MSc Epidemiology and Biostatistics, BSc Nursing, RM, RN
Measures of risk and association
Epidemiological Measurements of health
Cohort and longitudinal studies: statistics
Mortality Indicators and Morbidity Indicators
Risk Ratio A risk ratio, or relative risk, compares the risk of some health-related event such as disease or death in two groups. The two groups are typically.
Effect Modifiers.
Presentation transcript:

RATES AND RISK Daniel E. Ford, MD, MPH Johns Hopkins School of Medicine Introduction to Clinical Research July 12, 2010

RATES Cornerstone of comparison in clinical research studies Used to quantitate risk Used to compare events when sample size differs between treatment or exposure arms (usually the case)

Example We will describe the rates for different types of cancers

CHARACTERISTICS OF RATES Rates must have numerator, denominator and a time interval Time interval differentiates rates from proportions Everyone in the denominator must be at risk to be in the numerator Some “rates” are not really rates, e.g., crude birth rate, no. live births/total population/year. Only half the population can give birth!

DISEASE SURVEILLANCE IN A POPULATION OF 100 PERSONS

TYPES OF RATES Many types of rates Prevalence—proportion of individuals in a group with a specified condition during a defined period of time –Period vs. point prevalence –Prevalence of depression (in last week, last month, lifetime) Incidence—proportion of individuals in a group who develop a condition during a defined period of time

INCIDENCE AND PREVALENCE COMPARISON RateNumeratorDenominatorTime Frame Measurement IncidenceNew casesDisease-free at beginning of study Duration of follow up Prospective (incidence) study PrevalenceAll casesEveryone examined Usually one point in time (point) Cross sectional (prevalence) study

RELATIVE RISK Incidence rate is a measure of risk In clinical research often want to assess whether exposure to a risk factor or treatment (exposure) increases or decreases risk of disease Relative risk is the ratio of morbidity, mortality, or any outcome in those persons WITH the factor compared to those WITHOUT the factor

2 x 2 TABLE

SMOKING AND RISK OF LUNG CANCER

ATTRIBUTABLE RISK Difference in incidence between those treated or exposed compared to the untreated or unexposed group Population attributable risk is the product of the AR and prevalence of the risk factor

SMOKING AND RISK OF LUNG CANCER

Whelton and Klag, Drugs, 1986

RELATIVE RISK (RR) vs. ATTRIBUTABLE RISK (AR) RR of CVD associated with high (195 mmHg) versus low (105 mmHg) systolic blood pressure: –No risk factors: 150/75 per 1,000 per 8 yrs=2 –Smoking, chol, DM: 500/250 per 1,000 per 8 yrs=2 AR of CVD associated with high (195 mmHg) versus low (105 mmHg) systolic blood pressure: –No risk factors: =75 per 1,000 per 8 yrs –Smoking, chol, DM: = 250 per 1,000 per 8 yrs Which group would you rather be in?

RELATIVE VS. ATTRIBUTABLE RISK Relative risk assesses strength of the association, gauges magnitude of increased risk for an exposed group. Attributable risk estimates burden of disease associated with risk factor. PAR measures excess risk associated with a risk factor in the community, product of AR and risk factor prevalence

COMPARISON OF RATES Crude rates—may not be fair to compare crude rates between 2 groups, eg, death rates at JHH versus St. Joe’s. Variable specific rates—age, gender, race specific rates, eg, death rates for year old white women. –Allow fairer comparisons –Akin to matching –Can be cumbersome with multiple strata, eg, 6 age, 2 gender, 3 race groups

ADJUSTED RATES Adjusted rates—used to compare rates between groups or in the same population over time Most common methods of adjustment are: direct, indirect and multivariate analysis Multivariate is easiest and yields same results as direct adjustment Allows “fair” comparisons—holds adjustment variables constant –E.g., if age is the adjustment variable, differences in adjusted rates are not due to age

Incident ESRD patients. Rates adjusted for gender & race. INCIDENT COUNTS AND ADJUSTED RATES, BY AGE

Incident ESRD patients. Rates adjusted for age & race. INCIDENT COUNTS AND ADJUSTED RATES, BY GENDER

lla illi lla illi Incident ESRD patients. Rates adjusted for age & gender. INCIDENT COUNTS AND ADJUSTED RATES, BY RACE

How should we present data on efficacy of treatments? Events in control: 10/100 Events in treated: 5/100 Relative Risk Reduction = 50% reduction Absolute Risk Reduction = 5% reduction Number needed to treat = 20 1/(Pc – Pt)